OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Treatment algorithm for pulmonary arterial hypertension
Kelly Chin, Seán Gaine, Christian Gerges, et al.
European Respiratory Journal (2024) Vol. 64, Iss. 4, pp. 2401325-2401325
Open Access | Times Cited: 30
Kelly Chin, Seán Gaine, Christian Gerges, et al.
European Respiratory Journal (2024) Vol. 64, Iss. 4, pp. 2401325-2401325
Open Access | Times Cited: 30
Showing 1-25 of 30 citing articles:
Definition, classification and diagnosis of pulmonary hypertension
Gábor Kovács, Sonja Bartolome, Christopher P. Denton, et al.
European Respiratory Journal (2024) Vol. 64, Iss. 4, pp. 2401324-2401324
Open Access | Times Cited: 53
Gábor Kovács, Sonja Bartolome, Christopher P. Denton, et al.
European Respiratory Journal (2024) Vol. 64, Iss. 4, pp. 2401324-2401324
Open Access | Times Cited: 53
The comparative epidemiology, pathophysiology and management of cardiogenic shock associated with acute myocardial infarction and advanced heart failure
Varinder K. Randhawa, David A. Baran, Manreet Kanwar, et al.
Canadian Journal of Cardiology (2025)
Closed Access | Times Cited: 2
Varinder K. Randhawa, David A. Baran, Manreet Kanwar, et al.
Canadian Journal of Cardiology (2025)
Closed Access | Times Cited: 2
Exploring the patient perspective in pulmonary hypertension
H. James Ford, Colleen Brunetti, Pisana Ferrari, et al.
European Respiratory Journal (2024) Vol. 64, Iss. 4, pp. 2401129-2401129
Open Access | Times Cited: 5
H. James Ford, Colleen Brunetti, Pisana Ferrari, et al.
European Respiratory Journal (2024) Vol. 64, Iss. 4, pp. 2401129-2401129
Open Access | Times Cited: 5
Reply to: Treat-and-repair: a simple but powerful term for a complex multimodal approach in patients with pulmonary arterial hypertension associated with congenital heart disease
D. Dunbar Ivy, Erika B. Rosenzweig, Steven H. Abman, et al.
European Respiratory Journal (2025) Vol. 65, Iss. 1, pp. 2402127-2402127
Closed Access
D. Dunbar Ivy, Erika B. Rosenzweig, Steven H. Abman, et al.
European Respiratory Journal (2025) Vol. 65, Iss. 1, pp. 2402127-2402127
Closed Access
Sotatercept: A New Era in Pulmonary Arterial Hypertension
Suneesh Anand, Muhammad Furqan, Adriano R. Tonelli, et al.
Cardiology in Review (2025)
Closed Access
Suneesh Anand, Muhammad Furqan, Adriano R. Tonelli, et al.
Cardiology in Review (2025)
Closed Access
Sotatercept Use in a Patient with Pulmonary Arterial Hypertension Undergoing Lung Transplantation
J. Rosenheck, Kashika Goyal, Tara Fallah, et al.
JHLT Open (2025) Vol. 8, pp. 100213-100213
Open Access
J. Rosenheck, Kashika Goyal, Tara Fallah, et al.
JHLT Open (2025) Vol. 8, pp. 100213-100213
Open Access
Recent Advances in the Diagnosis and Management of Pulmonary Arterial Hypertension
Eamon Mullen, Brian McCullagh, Seán Gaine, et al.
British Journal of Hospital Medicine (2025), pp. 1-13
Closed Access
Eamon Mullen, Brian McCullagh, Seán Gaine, et al.
British Journal of Hospital Medicine (2025), pp. 1-13
Closed Access
Revisiting treatment of pulmonary arterial hypertension in the current era: A Greek scientific document
Eftychia Demerouti, Frantzeska Frantzeskaki, Tonia Adamidi, et al.
Hellenic Journal of Cardiology (2025)
Open Access
Eftychia Demerouti, Frantzeska Frantzeskaki, Tonia Adamidi, et al.
Hellenic Journal of Cardiology (2025)
Open Access
Future treatment paradigms in pulmonary arterial hypertension: a personal view from physicians, health authorities, and patients
Franck Rahaghi, Marc Humbert, Marius M. Hoeper, et al.
The Lancet Respiratory Medicine (2025)
Closed Access
Franck Rahaghi, Marc Humbert, Marius M. Hoeper, et al.
The Lancet Respiratory Medicine (2025)
Closed Access
“Diagnostic and therapeutic innovations in Pulmonary Hypertension: News from the 2024 World Symposium on Pulmonary Hypertension”
Isabel Blanco, Gábor Kovács
Archivos de Bronconeumología (2025)
Closed Access
Isabel Blanco, Gábor Kovács
Archivos de Bronconeumología (2025)
Closed Access
How a Most Unlikely Drug Changed the Outcome of Pulmonary Arterial Hypertension
Ivan M. Robbins, Anna R. Hemnes
Pulmonary Circulation (2025) Vol. 15, Iss. 1
Open Access
Ivan M. Robbins, Anna R. Hemnes
Pulmonary Circulation (2025) Vol. 15, Iss. 1
Open Access
Management of Pulmonary Arterial Hypertension: Current Strategies and Future Prospects
Munish Sharma, Vivek Paudyal, Saifullah Syed, et al.
Life (2025) Vol. 15, Iss. 3, pp. 430-430
Open Access
Munish Sharma, Vivek Paudyal, Saifullah Syed, et al.
Life (2025) Vol. 15, Iss. 3, pp. 430-430
Open Access
A real-world comparative effectiveness analysis of macitentan versus ambrisentan and bosentan on hospitalizations and healthcare resource utilization in patients with pulmonary arterial hypertension
Carly J. Paoli, Chang Zhi Zhang, Xiaoqin Tang, et al.
Respiratory Medicine (2025), pp. 108112-108112
Closed Access
Carly J. Paoli, Chang Zhi Zhang, Xiaoqin Tang, et al.
Respiratory Medicine (2025), pp. 108112-108112
Closed Access
Androgen receptor inhibitor ameliorates pulmonary arterial hypertension by enhancing the apoptosis level through suppressing the Notch3/Hes5 pathway
Jiayan Sun, Jiancheng Lin, Di Yin, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Jiayan Sun, Jiancheng Lin, Di Yin, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Comparative Analysis of Survival in Pulmonary Arterial Hypertension for Patients Treated with Selexipag in Clinical Practice (EXPOSURE Study)
Stefan Söderberg, Pilar Escribano Subías, Ciara Archey, et al.
Drugs - Real World Outcomes (2025)
Open Access
Stefan Söderberg, Pilar Escribano Subías, Ciara Archey, et al.
Drugs - Real World Outcomes (2025)
Open Access
(Current treatment options of pulmonary arterial hypertension in the Czech Republic, its limitations and perspectives, update of the therapeutic algorithm for pulmonary arterial hypertension. Expert consensus statement of the Working Group on Pulmonary Circulation of the Czech Society of Cardiology)
P Jansa, David Ambrož, Marián Felšöci, et al.
Cor et Vasa (2025) Vol. 67, Iss. 2, pp. 295-300
Open Access
P Jansa, David Ambrož, Marián Felšöci, et al.
Cor et Vasa (2025) Vol. 67, Iss. 2, pp. 295-300
Open Access
Pulmonary arterial hypertension and targeting pulmonary vascular remodelling: are we there yet?
James Lordan, Jason Weatherald
European Respiratory Journal (2025) Vol. 65, Iss. 5, pp. 2500322-2500322
Closed Access
James Lordan, Jason Weatherald
European Respiratory Journal (2025) Vol. 65, Iss. 5, pp. 2500322-2500322
Closed Access
BK Channels Are Indispensable for Endothelial Function in Small Pulmonary Arteries
Divya Guntur, D. Jeremic, Réka Csáki, et al.
Research Square (Research Square) (2025)
Closed Access
Divya Guntur, D. Jeremic, Réka Csáki, et al.
Research Square (Research Square) (2025)
Closed Access
Pulmonary Hypertension and Lung Transplantation
S. Kruszona, K. Aburahma, Nunzio Davide de Manna, et al.
Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie (2025)
Closed Access
S. Kruszona, K. Aburahma, Nunzio Davide de Manna, et al.
Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie (2025)
Closed Access
A new day has come: Sotatercept for the treatment of pulmonary arterial hypertension
Thomas Cascino, Sandeep Sahay, Victor Moles, et al.
The Journal of Heart and Lung Transplantation (2024)
Closed Access | Times Cited: 3
Thomas Cascino, Sandeep Sahay, Victor Moles, et al.
The Journal of Heart and Lung Transplantation (2024)
Closed Access | Times Cited: 3
Dehydrodiisoeugenol inhibits PDGF-BB-induced proliferation and migration of human pulmonary artery smooth muscle cells via the mTOR/HIF1-α/HK2 signaling pathway
Shishun Xie, Jianjun Zhao, Fan Zhang, et al.
Toxicology and Applied Pharmacology (2024) Vol. 495, pp. 117212-117212
Closed Access | Times Cited: 1
Shishun Xie, Jianjun Zhao, Fan Zhang, et al.
Toxicology and Applied Pharmacology (2024) Vol. 495, pp. 117212-117212
Closed Access | Times Cited: 1
Editorial on “Use of combined chemotherapy and immunotherapy improves pulmonary arterial hypertension”
Lindsay M. Forbes
Pulmonary Circulation (2024) Vol. 14, Iss. 3
Open Access | Times Cited: 1
Lindsay M. Forbes
Pulmonary Circulation (2024) Vol. 14, Iss. 3
Open Access | Times Cited: 1
Development and Validation of Quality Indicators for Pulmonary Arterial Hypertension Management in Japan: A Modified Delphi Consensus Study
Yuichi Tamura, Kazuya Hosokawa, Koshin Horimoto, et al.
Diagnostics (2024) Vol. 14, Iss. 23, pp. 2656-2656
Open Access | Times Cited: 1
Yuichi Tamura, Kazuya Hosokawa, Koshin Horimoto, et al.
Diagnostics (2024) Vol. 14, Iss. 23, pp. 2656-2656
Open Access | Times Cited: 1
Navigating between management of pulmonary arterial hypertension and cardiometabolic and pulmonary comorbidities
Hakim Ghani, Joanna Pepke‐Żaba
The Journal of Heart and Lung Transplantation (2024)
Closed Access
Hakim Ghani, Joanna Pepke‐Żaba
The Journal of Heart and Lung Transplantation (2024)
Closed Access
Tailoring oral anticoagulant treatment in the era of multi-drug therapies for PAH and CTEPH
Jean Escal, Géraldine Poenou, Xavier Delavenne, et al.
Blood Reviews (2024), pp. 101240-101240
Closed Access
Jean Escal, Géraldine Poenou, Xavier Delavenne, et al.
Blood Reviews (2024), pp. 101240-101240
Closed Access
